The use and timing of flow diversion for aneurysmal subarachnoid hemorrhage (SAH) is controversial. The objective of this study is to perform a meta-analysis and systematic review to compare overall complication rate between early versus delayed flow diversion for ruptured aneurysms.
Literature search for all eligible articles was performed using PubMed, Cochrane and Web of Science databases. The primary outcome was the overall complication rate (any complication in the perioperative period), and secondary outcomes were (1) hemorrhage and (2) stroke/death (all hemorrhagic/ischemic strokes and/or death).
Thirteen articles including 142 patients met inclusion criteria. Eighty-nine (62.7%) patients underwent early deployment of flow diverters (i.e., 2 days or less). The odds ratio for overall complication rate with early versus delayed flow diversion was 0.95 (95% CI=0.36-2.49, p=0.42). The odds ratio for the secondary outcome of hemorrhagic complication for early vs. delayed flow diversion was 1.44 (95% CI 0.45-4.52, p=0.87) and of stroke/death was 1.67 (95%CI 0.5-4.9, p=0.69). The odds ratio of early vs. delayed flow diversion for blister/dissecting/fusiform aneurysms was 0.82 (95% CI 0.29-2.30) and for saccular/giant aneurysms was 2.23 (95% CI 0.17-29.4). At last follow-up, 71.6% of patients had good performance status (mRS score 0-2), and the rate of angiographic aneurysm occlusion was 90.2%.
This meta-analysis did not show a difference in overall complication rate between early vs. delayed flow diversion for ruptured aneurysms. Early flow diversion for ruptured blister/fusiform/dissecting aneurysms carries a lower risk of aneurysm rerupture and overall complications as compared to that for ruptured saccular/giant aneurysms
(2019). Early versus delayed flow diversion for ruptured intracranial aneurysms: A meta-analysis. World Neurosurgery, 122(2), 1-34.
Available at: https://ecommons.aku.edu/pakistan_fhs_mc_surg_neurosurg/179
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial 4.0 License